COPD clinical trials in Illinois
19 studies for COPD are looking for participants at sites in Illinois.
Cities in Illinois
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Axis Clinical Trials - Westchester, Westchester
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- University of Illinois-Chicago - College of Medicine- Site Number : 8400055, Chicago
- Avicenna Clinical Research- Site Number : 8400126, Chicago Ridge
- NorthShore Medical Group - Evanston ( Endeavor Health)- Site Number : 8400073, Evanston
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Northwestern University, Chicago
- University of Chicago Medical Center, Chicago
- OSF Saint Francis Medical Center, Peoria
Recruiting
Ages 40 to 80 · All sexes · Updated Sep 17, 2026 · NCT06035120Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Christie Clinic in Champaign on University- Site Number : 8400023, Champaign
- Sneeze Wheeze & Itch Associates- Site Number : 8400020, Normal
- Peoria Pulmonary Associates Ltd- Site Number : 8400095, Peoria
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07190222Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Evanston
- Research Site, Springfield
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Palos Hills
- Research Site, Winfield
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305COPD Exacerbation Follow Up
- Advocate Lutheran General Hospital, Park Ridge
RecruitingObservational study
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT07118306A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Chicago
- Research Site, Winfield
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Aug 26, 2026 · NCT06283966STRIVE Post-Market Registry Study
- Northwestern University, Division of Pulmonary and Critical Care Medicine, Chicago
- University of Chicago, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT04302272Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Jesse Brown VA Medical Center, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT06390345SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Illinois Chicago, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 55 · All sexes · Updated Jun 3, 2026 · NCT05033990A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- Northwestern University, Chicago
Recruiting
Ages 22 and older · All sexes · Updated Jun 3, 2026 · NCT07119229Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Chicago, Chicago
- OSF St Francis Medical Center, Peoria
Recruiting
Ages 40 to 84 · All sexes · Updated Apr 24, 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Chicago
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Apr 9, 2026 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Chicago, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT06505603COPD Resources, Education, and Activity Designed for You Study
- Rush University Medical Center, Chicago
Recruiting
Ages 40 and older · All sexes · Updated Sep 22, 2025 · NCT07125053Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- University of Chicago, Chicago
- Walgreens, Deerfield
- Springfield Clinic, LLP, Springfield
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Chicago, Chicago
Recruiting
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.